2016
Lee, Yeon Sun, et al. “Various Modifications of the Amphipathic Dynorphin A Pharmacophore for Rat Brain Bradykinin Receptors.”. Chem Biol Drug Des, vol. 88, no. 4, Oct. 2016, pp. 615-9, https://doi.org/10.1111/cbdd.12789.
Zhao, Liqin, et al. “Sex Differences in Metabolic Aging of the Brain: Insights into Female Susceptibility to Alzheimer’s Disease.”. Neurobiol Aging, vol. 42, June 2016, pp. 69-79, https://doi.org/10.1016/j.neurobiolaging.2016.02.011.
Espeland, Mark A, et al. “Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention.”. Diabetes Care, vol. 39, no. 5, May 2016, pp. 764-71, https://doi.org/10.2337/dc15-2230.
Rettberg, Jamaica R, et al. “Identifying Postmenopausal Women at Risk for Cognitive Decline Within a Healthy Cohort Using a Panel of Clinical Metabolic Indicators: Potential for Detecting an At-Alzheimer’s Risk Metabolic Phenotype.”. Neurobiol Aging, vol. 40, Apr. 2016, pp. 155-63, https://doi.org/10.1016/j.neurobiolaging.2016.01.011.
Zhang, Yan, et al. “17-Cyclopropylmethyl-3,14β-Dihydroxy-4,5α-Epoxy-6β-(4’-Pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.”. ACS Chem Neurosci, vol. 7, no. 3, Jan. 2016, pp. 297-04, https://doi.org/10.1021/acschemneuro.5b00245.
Zhang, Liang, et al. “Altered Brain Energetics Induces Mitochondrial Fission Arrest in Alzheimer’s Disease.”. Sci Rep, vol. 6, Jan. 2016, p. 18725, https://doi.org/10.1038/srep18725.
Jenkins, Laura M, et al. “Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII) Betaglycan Modulates Canonical Wnt β-Catenin Signaling.”. J Biol Chem, vol. 291, no. 49, Jan. 2016, pp. 25716-28, https://doi.org/10.1074/jbc.M116.748624.
Cowell, Scott M, and Lee, Yeon Sun. “Biphalin: The Foundation of Bivalent Ligands.”. Curr Med Chem, vol. 23, no. 29, Jan. 2016, pp. 3267-84.
Lee, Yeon Sun, et al. “Cyclic Non-Opioid Dynorphin A Analogues for the Bradykinin Receptors.”. Bioorg Med Chem Lett, vol. 26, no. 22, Jan. 2016, pp. 5513-6, https://doi.org/10.1016/j.bmcl.2016.10.010.
Remesic, Michael, et al. “Cyclic Opioid Peptides.”. Curr Med Chem, vol. 23, no. 13, Jan. 2016, pp. 1288-303.
Hall, Sara M, et al. “Discovery of Stable Non-Opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.”. ACS Chem Neurosci, vol. 7, no. 12, Jan. 2016, pp. 1746-52, https://doi.org/10.1021/acschemneuro.6b00258.
Hall, Sara M, et al. “Dynorphin A Analogs for the Treatment of Chronic Neuropathic Pain.”. Future Med Chem, vol. 8, no. 2, Jan. 2016, pp. 165-77, https://doi.org/10.4155/fmc.15.164.
Deekonda, Srinivas, et al. “Enkephalin Analogues With N-Phenyl-N-(piperidin-2-Ylmethyl)propionamide Derivatives: Synthesis and Biological Evaluations.”. Bioorg Med Chem Lett, vol. 26, no. 1, Jan. 2016, pp. 222-7, https://doi.org/10.1016/j.bmcl.2015.10.081.
Islam, Mohammad Rashedul, et al. “Enkephalin-Fentanyl Multifunctional Opioids As Potential Neuroprotectants for Ischemic Stroke Treatment.”. Curr Pharm Des, vol. 22, no. 42, Jan. 2016, pp. 6459-68, https://doi.org/10.2174/1381612822666160720170124.
Brinton, Roberta Diaz. “Neuroendocrinology: Oestrogen Therapy Affects Brain Structure But Not Function”. Nat Rev Neurol, vol. 12, no. 10, Jan. 2016, pp. 561-2, https://doi.org/10.1038/nrneurol.2016.147.
Shah, Nirav, and Lee, Nam Y. “Regulation of Gene Expression and Mitochondrial Dynamics by SMAD.”. Mol Cell Oncol, vol. 3, no. 5, Jan. 2016, p. e1204492, https://doi.org/10.1080/23723556.2016.1204492.
Kumar, Niyanta N, et al. “Relative Vascular Permeability and Vascularity across Different Regions of the Rat Nasal Mucosa: Implications for Nasal Physiology and Drug Delivery.”. Sci Rep, vol. 6, Jan. 2016, p. 31732, https://doi.org/10.1038/srep31732.
Moutal, Aubin, et al. “Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.”. Mol Neurobiol, Jan. 2016, https://doi.org/10.1007/s12035-016-9907-1.
Ramos-Colon, Cyf N, et al. “Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor.”. J Med Chem, vol. 59, no. 22, Jan. 2016, pp. 10291-8, https://doi.org/10.1021/acs.jmedchem.6b01411.
Wang, Yiwei, and Brinton, Roberta D. “Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex.”. Front Aging Neurosci, vol. 8, Jan. 2016, p. 232, https://doi.org/10.3389/fnagi.2016.00232.
2015
Espeland, Mark A, et al. “Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.”. Diabetes Care, vol. 38, no. 12, Dec. 2015, pp. 2316-24, https://doi.org/10.2337/dc15-1385.
Klosinski, Lauren P, et al. “White Matter Lipids As a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer’s Disease.”. EBioMedicine, vol. 2, no. 12, Dec. 2015, pp. 1888-904, https://doi.org/10.1016/j.ebiom.2015.11.002.
Varadaraj, Archana, et al. “Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia.”. Neoplasia, vol. 17, no. 11, Nov. 2015, pp. 826-38, https://doi.org/10.1016/j.neo.2015.11.003.
Harshman, Dustin K, et al. “Innovative QPCR Using Interfacial Effects to Enable Low Threshold Cycle Detection and Inhibition Relief.”. Sci Adv, vol. 1, no. 8, Sept. 2015, p. e1400061, https://doi.org/10.1126/sciadv.1400061.
Pagination
- First page
- …
- 7
- 8
- 9
- …
- Last page